The DEA is approving a synthetic marijuana that could potentially be deadly. Cenk Uygur and Ana Kasparian, the hosts of The Young Turks, tell you how the DEA is in the pocket of big pharma.
“A pharmaceutical company which donated $500,000 to a marijuana opposition group has received DEA approval to produce Syndros, a synthetic marijuana drug.
Insys Therapeutics, which produces the Syndros drug, funded about 10 percent of money raised by Arizonans for Responsible Drug Policy, an anti-marijuana campaign that opposed Arizona’s recreational marijuana ballot measure during the 2016 election, The Washington Post reported Thursday. Insys was the only pharmaceutical company on record that had donated to the opposition group, which was successful in persuading voters to reject the recreational bill.
Along with donating to campaigns opposing marijuana legalization, Insys has been an active advocate for marijuana restrictions, particularly medicines using marijuana’s psychoactive ingredient, THC. During the 2016 election, the company said it backed Arizona’s anti-marijuana measures because legalizing the plant failed to “protect the safety of Arizona’s citizens, and particularly its children.””